About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
A valuable book provides practical advice for readers and their families about how to prepare for surgery.
Focus on Medicare
Dr. Goldenberg discusses how Hatch–Waxman “got the hatchet.”
Marvin M. Goldenberg, PhD, RPh, MS
Dr. Stefanacci addresses some unanswered questions about the new Medicare drug benefit; for example, how many drugs will be needed to meet the formulary requirement, how will the formularies be designed, and how will the appeals process work?
Richard G. Stefanacci, DO, MGH, MBA, CMD
Dr. Prescott reports on new therapies for non-Hodgkin’s and mantle-cell lymphomas, myeloid and myelomonocytic leukemias, myelodysplastic syndromes, myelodysplasia, oral mucositis, polycythemia vera, and other disorders of the blood.
Lawrence M. Prescott, PhD
Continuing Education Credit
Dr. Talbert reviews current therapies for lipid disorders and emphasizes the need for monitoring patients and promoting their adherence to treatment guidelines.
Robert L. Talbert, PharmD, BCPS
David Nash, MD, MBA, discusses the need for health care providers and drug companies to “seek middle ground” in avoiding conflicts of interest.
David B. Nash, MD, MBA
Stephen Barlas perceives some pitfalls with the new Medicare Drug Discount Cards.
Matthew Grissinger, RPh, FASCP, stresses the need to maintain patient safety despite the current trend of staff reductions.
Matthew Grissinger, RPh, FASCP
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new medical devices.
Drs. Hilas and Marzella review FluMist™, a live, attenuated influenza vaccine.
Olga Hilas, BS, PharmD, and Nino Marzella, BS, PharmD